OMISIRGE

This brand name is authorized in United States.

Active ingredients

The drug OMISIRGE contains one active pharmaceutical ingredient (API):

`1`	Omidubicel UNII `ET4JC4S66E` - OMIDUBICEL
	Omidubicel is a nicotinamide (NAM) modified allogeneic hematopoietic progenitor cell therapy derived from cord blood used as an allogeneic stem cell donor source. Omidubicel is manufactured utilizing a proprietary NAM based technology producing enriched HPCs.
	Read more about Omidubicel

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
OMISIRGE Suspension for solution for infusion	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	73441-100, 73441-200, 73441-300, 73441-400, 73441-800

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.